Abstract
Nucleic acid nanoparticles are playing an increasingly important role in biomolecular diagnostics and therapeutics as well as a variety of other areas. The unique attributes of self-assembling DNA nanoparticles provide a potentially valuable addition or alternative to the lipid-based nanoparticles that are currently used to ferry nucleic acids in living systems. To explore this possibility, we have assessed the ability of self-assembling DNA nanoparticles to be constructed from complete gene cassettes that are capable of gene expression in vitro. In the current report, we describe the somewhat counter-intuitive result that despite extensive crossovers (the stereochemical analogs of Holliday junctions) and variations in architecture, these DNA nanoparticles are amenable to gene expression as evidenced by T7 RNA polymerase-driven transcription of a reporter gene in vitro. These findings, coupled with the vastly malleable architecture and chemistry of self-assembling DNA nanoparticles, warrant further investigation of their utility in biomedical genetics.
Subject terms: Biological techniques, Biotechnology, Genetics, Structural biology
Introduction
Self-assembling nucleic acid nanosystems (i.e., DNA nanoparticles) provide an architecturally and chemically malleable platform for a wide range of applications1–8. Exemplary uses of DNA nanoparticles include targeted drug delivery1–3,5,6,8–16, biosensing1,3,5,7,17, nanoelectronics3,6,12,18, bioimaging1, nanorobotics2,3,5,12, nanophotonics5,7,17,18, CpG triggered immunostimulation2,5,11,12, synthetic nanopore formation1, templates for CRISPR-mediated in vivo genomic integration followed by gene expression19 and, recently, as gene expression vehicles in cell culture20. Although DNA is inherently immunogenic, it can be chemically modified to tune its biocompatibility1–3,7,8. Thus, there may be additional opportunities in biomedicine for functional DNA nanoparticles with nuanced immunological properties.
The M13 bacteriophage ssDNA genome has been the workhorse scaffold for DNA nanoparticles constructed by the method of DNA origami21. As methods and applications of DNA nanotechnology have expanded there has been a corresponding increased interest in the use of scaffolds other than M13 ssDNA22,23. Nonetheless, even with the availability of a larger library of single-stranded scaffolds now accessible, the vast majority of DNA nanoparticle applications focus on the use of the scaffold as an engineering component for sculpting DNA nanoparticle architecture and function with less attention paid to its genetic code content1,2,9,13.
In this report, we return focus to the genetic information in the scaffold of DNA nanoparticles to evaluate whether this information may still be biologically active even when folded and containing numerous crossover junctions. We find that variously sculpted DNA nanoparticles containing a full gene cassette can be transcribed in vitro. This finding suggests that it may be feasible to employ self-assembling DNA nanosystems as a platform for delivery of biologically active, intentionally sculpted, and camouflaged gene cassettes to specific locations in cell culture and even in vivo wherein they may be expressed with or without the requirement of chromosomal insertion19,20.
Materials and methods
Gene-bearing DNA origami scaffolds were prepared as previously described24, summarized as follows.
Standard PCR
Primers for amplification of the Green Fluorescent Protein (GFP) gene were designed using SnapGene and purchased from Integrated DNA Technologies (IDT, Coralville, IA, USA). The sequence of each primer is listed in Supplementary Table 1. Phusion® polymerase for the PCR reaction was purchased from New England Biolabs (NEB, Ipswich, MA, USA).
For the generation of a duplex gene containing all components for transcription, each PCR reaction mixture was prepared in 50 µL final volume, composed of 1 × Phusion® HF buffer (NEB), 200 nM dNTP mix (NEB), 500 nM sense primer (T7EGFP sense = undesired sense strand), 500 nM antisense primer (T7EGFP anti = desired antisense strand), 10 ng plasmid template (pCMV-T7-EGFP; Addgene, Watertown, MA, USA), 0.5 µL Phusion® DNA polymerase, and nuclease-free water to volume. Each PCR was performed using the following thermocycler steps: 30 s at 98 °C, 30 s at 58 °C, and 1 min at 72 °C for 30 cycles24.
For the generation of duplex gene missing promoters, each PCR reaction mixture was prepared in 50 µL final volume, composed of 1 × Phusion® HF buffer (NEB), 200 nM dNTP mix (NEB), 500 nM sense primer (RT-sense), 500 nM antisense primer (T7EGFP anti), 10 ng pCMV-T7-EGFP (Addgene), 0.5 µL Phusion® DNA polymerase, and nuclease-free water to volume. Each PCR was performed using the following thermocycler steps: 30 s at 98 °C, 30 s at 59 °C, and 1 min at 72 °C for 30 cycles24.
The reaction products were mixed with 6 × loading dye (15% Ficoll®-400, 60 mM EDTA, 19.8 mM Tris–HCl, 0.48% SDS, 0.12% Dye 1, 0.006% Dye 2, pH 8 at 25 °C; NEB) and then loaded onto a 1% agarose gel pre-stained with SYBR safe DNA dye (Invitrogen, Waltham, MA, USA). Electrophoresis was carried out at 8 V/cm for 1 h. The SYBR Safe-containing DNA was visualized using a 490 nm wavelength (blue) transilluminator and an amber filter24.
Asymmetric PCR (aPCR)
Primers used in aPCR were identical to those used in standard PCR. Along with sense and antisense primers, a 3’ terminal modified primer (3’ T7EGFP blocker) was used. The 3’ T7EGFP blocker was designed using SnapGene and purchased from IDT. Its sequence is listed in Supplementary Table 1.
For the generation of a scaffold containing all components for transcription, each aPCR reaction was carried out in 50 µL total volume, composed of 1 × LongAmp® Taq buffer (60 mM Tris-SO4, 20 mM (NH4)2SO4, 2 mM MgSO4, 3% glycerol, 0.06% IGEPAL® CA-630, 0.05% Tween® 20, pH 9.1 at 25 °C) from NEB, 500 nM T7EGFP anti, 25 nM T7EGFP sense, 475 nM 3’ T7EGFP blocker, 300 nM dNTP mix from NEB, 10 ng double-stranded GFP gene (dsT7EGFP; generated by standard PCR), 2 µL LongAmp® Taq DNA polymerase (NEB), and nuclease-free water to final volume. Each aPCR was performed using the following thermocycler steps: 30 s at 94 °C, 30 s at 58 °C, and 2 min at 65 °C for 25 cycles24.
For the generation of a scaffold containing all components for transcription except the promoter element, each PCR reaction was carried out in 50 µL total volume, composed of 1 × LongAmp® Taq buffer (60 mM Tris-SO4, 20 mM (NH4)2SO4, 2 mM MgSO4, 3% glycerol, 0.06% IGEPAL® CA-630, 0.05% Tween® 20, pH 9.1 at 25 °C) from NEB, 1 µM T7EGFP anti, 20 nM RT sense, 300 nM dNTP mix from NEB, 10 ng double-stranded GFP gene devoid of promoters (dsT7EGFP -T7; generated by standard PCR), 2 µL LongAmp® Taq DNA polymerase (NEB), and nuclease-free water to final volume Each aPCR was performed using the following thermocycler steps: 30 s at 94 °C, 30 s at 59 °C, and 2 min at 65 °C for 25 cycles24.
The reaction product was loaded onto a 1% agarose gel pre-stained with 1 × SYBR Safe (Invitrogen), electrophoresed, and visualized as above.
Double-stranded DNA (dsDNA) purification
A Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA, USA) was used to extract dsDNA from agarose gels. Gel bands containing target dsDNA were removed using a clean razor blade. Three times the gel slice volume of the provided agarose dissolving/binding buffer was added to each gel fragment and incubated at 55 °C on a heat block for 15 min. Each dissolved gel solution was transferred to a provided silica-based spin column and centrifuged at 10,000 relative centrifugal force (rcf) for 60 s in a table-top centrifuge. 200 µL of ethanol-based DNA wash buffer was added to each spin column and centrifuged at 10,000 rcf for 30 s. A washing step was repeated before centrifuging at 10,000 rcf for 60 s for the complete removal of ethanol. Flow-through from all steps was discarded. After transferring each spin column to a clean microcentrifuge tube, 6–20 µL of the provided elution buffer (10 mM Tris–HCl, 0.1 mM EDTA, pH 8.5) was added directly to the matrix of each spin column followed by centrifugation at 10,000 rcf for 60 s for DNA collection. A fraction of each purified dsDNA was mixed with 6 × loading dye (NEB) and loaded onto 1% agarose gel pre-stained with 1 × SYBR safe (Invitrogen). The gel was run at 8 V/cm for 1 h. The yield of the purified dsDNA sample was evaluated by measuring band intensities relative to a known control using GelAnalyzer 19.1 available at www.gelanalyzer.com (accessed on 19 August 2021)24.
Single-stranded (ssDNA) purification
A Zymoclean Gel RNA Recovery Kit from Zymo Research was used to purify ssDNA from agarose gels. The gel bands containing target ssDNA were excised with a clean razor blade. Three times the gel slice volume of the provided agarose dissolving/binding buffer was added to each excised gel band and melted at 55 °C on a heat block for 15 min. Each dissolved gel solution was transferred to a provided silica-based spin column and centrifuged at 12,000 rcf for 2 min. 400 µL RNA Prep buffer was added to each spin column followed by centrifugation at 12,000 rcf for 1 min. Washing was carried out by the addition of 800 µL ethanol-based wash buffer followed by centrifugation at 12,000 rcf for 30 s. After repeating the washing step with 400 µL ethanol-based wash buffer, each spin column was centrifuged at 12,000 rcf for 2 min to remove residual ethanol. Flow-through in all steps was discarded. After transferring each spin column to clean microcentrifuge tubes, 6–20 µL of provided nuclease-free water was added directly to the column matrix, and the spin columns were centrifuged at 10,000 rcf for 1 min for retentate collection. A fraction of each purified ssDNA was mixed with 6 × loading dye (NEB) and the yield was estimated by gel electrophoresis as described above24.
DNA nanoparticle construction
DNA nanoparticles were designed using caDNAno (www.cadnano.org) and staples were purchased from IDT (Supplementary Tables 2 and 3). DNA nanoparticles were prepared by mixing single-stranded GFP gene (ssT7EGFP or ssT7EGFP -T7; generated by aPCR) to a final concentration of 91.4 nM and each staple to a final concentration of 457 nM in 1 × TAE buffer supplemented with 12.5 mM Mg(OAc)2 (TAEM) in a final volume of 50 µL. The staple set for each DNA nanoparticle is listed in Supplementary Table 4. The mixture was incubated at 90 °C for 10 min in a water bath followed by gradual cooling to room temperature. Products of this reaction were mixed with 6 × loading dye (NEB) and then loaded onto 1% agarose gel containing 12.5 mM Mg(OAc)2 pre-stained with 1 × SYBR Safe DNA dye (Invitrogen). Electrophoresis was carried out in TAEM buffer at 6 V/cm for 90 min. The gel was visualized as above. DNA origami was purified using a Freeze ‘N Squeeze™ DNA Gel Extraction Spin Column (Bio-Rad, Hercules, CA, USA). Gel bands containing target DNA origami were sliced and removed using a clean razor blade, then transferred to Freeze ‘N Squeeze™ DNA Gel Extraction Spin columns. Spin columns containing target DNA origami gel slices were incubated at − 20 °C for 5 min followed by centrifugation at 13,000 rcf in a table-top centrifuge for 3 min at room temperature. The concentration of the purified DNA origami samples was measured using a NanoDrop™ instrument.
In vitro transcription (IVT)
All IVT reactions were carried out in 20 µL total volume using a HiScribe® T7 Quick High Yield RNA Synthesis Kit (NEB). Each reaction contained 10 µL NTP buffer mix (10 mM each NTP; NEB), 10 ng DNA template (linearized GFP plasmid (LpCMV-T7-EGFP), dsT7EGFP, ssT7EGFP, each DNA nanoparticle (designated as described in Table 1 below and in the legend for Fig. 2b), 2 µL T7 RNA polymerase mix, and nuclease-free water to volume. Each reaction was carried out at 37 °C for 2 h. For T7GHL FS, T7GHL PO, and T7GHL HS, a reaction time course of 30, 60, 90, and 120 min was carried out for a preliminary comparison of the relative transcription rates of these constructs and substrate longevity.
Table 1.
Name | Contents |
---|---|
ssT7EGFP | Single-stranded antisense strand for nanoparticle scaffold |
ssT7EGFP -T7 | Single-stranded antisense strand for nanoparticle scaffold lacking the T7 promoter |
T7GHL PO | DNA nanoparticle with a linear duplex promotor and single-stranded GFP gene; variant of T7-based GFP gene Honeycomb structure with a Linear promoter, the Promoter Only being in duplex form within the structure |
T7GHL HS | DNA nanoparticle with a linear duplex promotor and a half complement of staples (i.e., loosely folded); variant of T7-based GFP gene Honeycomb structure with a Linear promoter, the structure folded with a Half-Set of staples |
T7GHL FS | DNA nanoparticle with a linear duplex promotor and a full complement of staples (i.e., tightly folded); variant of T7-based GFP gene Honeycomb structure with a Linear promoter, the structure folded with a Full-Set of staples |
T7GHL BP | DNA nanoparticle with a linear duplex promotor that is buried within a folded architecture with a full complement of staples (i.e., buried promoter, tightly folded); variant of T7-based GFP gene Honeycomb structure with a Linear promoter; the structure with Buried Promoter inside the structure |
T7GHL -T7 | DNA nanoparticle with a full complement of staples but lacking the T7 promoter sequence; variant of T7-based GFP gene Honeycomb structure with a Linear promoter, the structure lacking (-) T7 promoter |
Purification of IVT products
Following IVT, 30 µL of nuclease-free water was added to each IVT reaction product to increase the reaction volume. Each IVT product was then purified using a Monarch® RNA Cleanup Kit (NEB). 100 µL of RNA binding buffer was added to each 50 µL IVT product followed by the addition of 150 µL of absolute ethanol. Each mixture was then transferred to a provided silica-based spin column and centrifuged in a table-top centrifuge. 500 µL of ethanol-based DNA wash buffer was added to each spin column and centrifuged as above. The washing step was repeated once more and the flow-through from all steps was discarded. Each spin column was transferred to a clean microcentrifuge tube and 10 µL of the provided nuclease-free water was added directly to the matrix of each spin column followed by centrifugation for DNA collection. All centrifugation steps were carried out in 16,000 rcf for 60 s.
Evaluation of IVT products
IVT products from all DNA samples were analyzed by gel electrophoresis. Purified GFP PCR and linearized GFP plasmid IVT products were diluted 100-fold to avoid over-staining. Purified RNA products were mixed with an equal volume of 2 × RNA loading dye (95% formamide, 0.02% SDS, 0.02% bromophenol blue, 0.01% Xylene Cyanol, 1 mM EDTA; NEB). Samples were heated to 70 °C for 10 min prior to gel loading. Electrophoresis was carried out at 8 V/cm for 1 h. The gels were post-stained with 1 × TAE solution containing 1 × SYBR gold (Invitrogen) for 2 h. The stained gels were visualized using a 490 nm wavelength transilluminator and an amber filter.
Reverse transcription PCR (RT-PCR)
RNA templates for RT-PCR were prepared by carrying out an IVT reaction using each DNA template (LpCMV-T7-EGFP, dsT7EGFP, ssT7EGFP, T7GHL PO, T7GHL HS, T7GHL FS, and T7GHL BP) as described above. To minimize the possible background signal caused by the presence of residual DNA template, 1 ng of each DNA template (rather than 10 ng) was used for these reactions, and the incubation time was extended to overnight to maximize RNA production under these conditions. Following IVT, DNA was hydrolyzed by treatment with DNase. A 50 µL DNase mixture was prepared by mixing 20 µL IVT product with 2 µL RNase-free DNase-I and nuclease-free water to volume. All DNase reactions were carried out at 37 °C for 30 min. DNase-treated RNA products were purified using a Monarch® RNA Cleanup Kit (NEB) as described above. Primers for amplification of the GFP gene were designed using SnapGene and purchased from IDT. The sequence of each primer is listed in Supplementary Table 1. RT-PCR was performed using a OneTaq® One-step RT-PCR kit (NEB). Each RT-PCR mixture was carried out in 50 µL final volume, containing 1 × Quick-Load® OneTaq One-step reaction mix (1.6 mM MgCl2, 250 nM dNTP mixture), 400 nM sense primer (RT-sense), 400 nM antisense primer (RT-anti), 1 µL of each purified RNA product, 1 × OneTaq® One-step enzyme mix (ProtoScript® II reverse transcriptase, OneTaq® Hot Start DNA polymerase, Murine RNase inhibitor, and stabilizer), and nuclease-free water to volume. To assess any contribution to PCR signal from residual DNA resulting from incomplete DNase hydrolysis, negative controls were prepared in parallel. These reactions contained the same components as RT-PCR mixtures but substituted OneTaq® Hot Start DNA polymerase for the OneTaq® One-step enzyme mix (i.e., lacking reverse transcriptase altogether). In this case, any signal represented the amplification of residual DNA remaining after DNase treatment. Reactions were carried out by treating each RT-PCR mixture at 48 °C for 30 min followed by PCR. Each PCR was performed using the following thermocycling steps: 30 s at 94 °C, 30 s at 60 °C, and 1 min at 68 °C for 15 cycles. Each product was loaded onto a 1% agarose gel pre-stained with SYBR-safe DNA dye (Invitrogen). The gel was electrophoresed and visualized as above.
Transmission electron microscopy (TEM)
TEM was performed as previously described25. Briefly, samples for TEM imaging were prepared in a concentration range of 0.5 nM to 5 nM. 12 μL of the sample was placed on glow-discharged carbon-coated 400 mesh copper TEM grids. After two minutes of incubation, the sample solution was removed using filter paper and replaced with 12 μL of freshly prepared uranyl formate negative staining solution. The stain was removed after 30 s, and the grids were air-dried. TEM images were acquired at 25,000 × magnification using a JEOL 1230 TEM (Peabody, Ma, USA) equipped with a Gatan Inc. 2 k × 2 k Ultrascan camera (Pleasanton, CA, USA)25.
Results
DNA nanoparticle construction
The overall process of generating the DNA nanoparticles used in this study is illustrated in Fig. 1. For the construction of potentially transcription-capable DNA nanoparticles, a custom scaffold was synthesized that contained the required gene sequence elements for expression. These scaffolds included a T7 promoter, the GFP gene, and a poly A signal (a CMV promoter and enhancer, not relevant to the present study, were also present). Conventional PCR followed by asymmetric PCR (aPCR) was performed to produce the single-stranded scaffold containing the GFP gene cassette, designated ssT7EGFP and ssT7EGFP -T7, the latter lacking the T7 promotor as a negative control (Table 1). The same primers were used for both PCR and aPCR, but in the case of the aPCR, an unequal ratio of primers was employed to enhance the production of the desired strand (the genetically defined antisense strand). A 3’ terminal blocker was used along with both sense and antisense primers to optimize the production of the desired strand by aPCR. Electrophoretic analysis of the products of this process revealed two bands estimated to be ~ 1700 bp and ~ 900 bp in length as determined by co-migration with dsDNA markers (Fig. 2a). Both the dsT7EGFP and the ssT7EGFP are 1771 nucleotides in length. However, the single-stranded form migrates faster under non-denaturing conditions presumably due to internal base-pairing. Thus, we interpret the strong DNA band at ~ 1700 bp as being dsT7EGFP and the band at approximately 900 bp to be the desired ssT7EGFP. This interpretation was corroborated by the difference in SYBR Safe DNA dye color and staining efficiency24 and further validated by the use of the presumed ssDNA band for the successful construction of DNA origami nanoparticles (below).
The program caDNAno26 was employed to design the DNA nanoparticles used in this study. ssT7EGFP was used to construct nanoparticle architectures designated T7GHL PO, T7GHL HS, T7GHL FS, and T7GHL BP, and ssT7EGFP -T7 was used to construct T7GHL -T7 (Fig. 2b, and Supplementary Fig. 1). Details regarding the acronyms of the DNA nanoparticles are listed in Table 1. A schematic diagram of the structures of each DNA nanoparticle is also provided in Fig. 1. These nanoparticles were designed to form a cylindrical shape, maintaining a crossover pattern that was relatively consistent throughout various forms of this general structure. With the exception of a T7GHL BP in which the T7 promoter is buried within the nanoparticle architecture, the promoter of the GFP gene constructs was configured as a linear (i.e., no crossovers) double-stranded DNA helix adjacent to the cylindrical core (Supplementary Fig. 1). The intent of external positioning of the T7 promoter was due to a naïve assumption that it was advantageous to optimize accessibility to the promoter by T7 polymerase. To test the validity of this assumption the T7GHL BP construct was designed with the promotor sequestered inside the cylindrical architecture with crossover density consistent with the rest of the nanoparticle architecture. Single-stranded hairpins were positioned at the ends of each double helix in all constructs to facilitate the folding process (Supplementary Fig. 1).
To assess the efficiency of transcription as a function of the number of crossovers employed (“compactness”), DNA nanoparticles were constructed with varying staple density (Supplementary Fig. 1). Also, to evaluate whether the IVT products were the result of promoter-based transcription rather than random priming, one of the nanoparticles was constructed with a scaffold that was devoid of any T7 promoter sequence elements. Electrophoretic analysis of the DNA nanoparticle constructs revealed band shifts that were distinct from ssT7EGFP and dsT7GFP (Fig. 2b), indicating the successful self-assembly of the intended DNA nanoparticles. To minimize contamination from staples and incomplete or aberrantly folded structures that might hamper the interpretation of IVT data27, all constructs were gel purified (Fig. 2b). Freeze-and-squeeze gel purification is a commonly used method to obtain intact ultrapure DNA nanoparticles19,28. Thus, the freeze-and-squeeze gel purification method was employed for the purification of DNA nanoparticles used in the study. Confirmation of the retention of the structural integrity of the DNA nanoparticles used in this study was obtained by TEM imaging of gel-purified samples (Fig. 3).
In vitro transcription (IVT)
IVT analysis was performed using the T7 promotor and a commercial T7 polymerase IVT kit (NEB). Positive controls included a linearized GFP plasmid (LpCMV-T7-EGFP) and the linear duplex GFP PCR product (dsT7EGFP) to assess the expected maximum degree of RNA production. A single-stranded antisense strand (i.e., the bare origami scaffold; ssT7EGFP) was used as a negative control based on the reported requirement for a double-stranded T7 promoter for successful transcription30,31. The IVT reactions from positive controls (dsT7EGFP and LpCMV-T7-EGFP) generated substantial quantities of RNA products and, therefore, these products were diluted 100-fold for clear visualization by electrophoresis. Banding patterns on non-denaturing (native) and denaturing gels were virtually identical, thus, the bulk of these analyses was carried out under non-denaturing conditions. Size estimates were based on a calibrated RNA ladder from a commercial supplier (NEB).
Electrophoretic analysis of IVT products revealed two RNA bands with approximate sizes of 1100 nucleotides (nt) and 900 nt (Fig. 4). IVT of linearized GFP plasmid resulted in RNA products with approximate sizes of 1300 nt and 900 nt. The larger product is consistent with the expected full-length transcript for linearized GFP plasmid which is 200 bp longer than the PCR-generated linear duplex, dsT7EGFP. Denaturing PAGE ruled out the possibility that the 900 nt product was a stable folded (i.e., internally base-paired) form of the 1100 nt long product. Previous studies have shown that sequence 5’ ATCTGTT 3’ can be responsible for the pausing or termination of T7 RNA polymerase32,33. The target DNA in these studies contains this sequence near the 3’ end and termination at this position would create an RNA product of the observed size. Thus, it is likely that the aforementioned termination sequence is responsible for the smaller of the two different RNA products observed. The electrophoretic results also revealed bands at approximately 2.5 kb in general and 1.5 kb in the T7GHL-T7 lane. Given that the templates for the IVT reaction did not exceed 2.5 kb (i.e., the 2500 nt product cannot be an RNA product because the templates were much shorter than 2 kb) and the ssRNA ladder used in Fig. 4 was not a dependable standard for measuring the size of dsDNA, it is reasonable to conclude that the bands around 2.5 kb represent residual DNA templates (Fig. 4).
Based on previous reports involving the study of the requirements of a duplex promoter for transcriptional activity, we assumed that a fully single-stranded promoter would preclude transcription initiation30,31. However, ssT7EGFP, the fully single-stranded antisense scaffold, was transcribed and produced RNA products that were indistinguishable from those produced by the positive controls. Sequence analysis revealed that portions of ssT7EGFP contain partial sequence complementarity to the promoter region. Previous studies have shown that partial complementarity of this nature is sufficient to support T7 promoter function34. Thus, our current hypothesis is that a foldback structure mediated by partial T7 promoter complementarity permitted low-level transcription initiation with purely single-stranded template DNA.
Electrophoretic analysis of IVT products from the structured DNA nanoparticles used in this study revealed banding patterns identical to the positive controls. All of the DNA nanoparticles tested produced identically sized RNA products except for the negative control DNA nanoparticle that was completely devoid of the T7 promoter element (Fig. 4). To assess whether DNA nanoparticles retain their structural integrity under IVT reaction conditions, T7GHL FS was incubated under IVT reaction conditions in the absence of T7 RNA polymerase and in the presence of increasing magnesium ion concentration (Mg2+; known to enhance the formation and stability of DNA origami nanoparticles21). The result was analyzed by gel electrophoresis. The banding pattern revealed no obvious change in DNA nanoparticle migration upon increasing Mg2+ concentration suggesting that the DNA nanoparticles used in this study maintain their structural integrity under the conditions used for IVT reactions (Supplementary Fig. 2). Moreover, we observed an inverse correlation between “compactness” (i.e., crossover density) of the DNA nanoparticles used in this study and RNA production. This strengthens the suggestion that the DNA nanoparticles remain intact under T7 RNA polymerase reaction conditions and that T7 RNA polymerase, though capable of transcribing through crossovers, is increasingly impeded as the number of crossovers increases.
T7GHL BP (buried promoter) was designed to test whether impeding access to the promoter by positioning it in an internal region of a DNA nanoparticle can block transcription. In contrast to expectations, this architecture supported RNA production, but at a slightly reduced level in comparison to the other constructs (Fig. 4). As mentioned above, DNA nanoparticles were observed to maintain structural integrity under IVT reaction conditions as assessed by gel electrophoresis. Yet, to fully exclude the possibility of a “loosened” structure permitting access to the promoter to the T7 RNA polymerase, various concentrations of magnesium ions were introduced into the IVT reaction (Supplementary Fig. 3). The production of RNA was not impacted by the increase in magnesium ion concentration, contradicting the hypothesis that a loosened architecture was the primary reason the buried promoter architecture still permitted transcription. The crystal structure of T7 RNA polymerase reveals its overall dimensions to be 75 Å × 75 Å × 65 Å35. The most compact DNA nanoparticle architecture used in this study, T7GHL BP, retains at least 21 bases between any two crossovers connecting adjacent helices, corresponding to a distance of 71.4 Å. Thus, it is reasonable to hypothesize that the T7 RNA polymerase single-subunit enzyme is capable of accessing the T7 promoter inside the structure.
RT-PCR
To verify that the observed IVT products were indeed GFP RNA transcripts, RT-PCR was performed. Primers were designed to cover the GFP gene. For these experiments, the amount of template used for IVT was titrated to minimize the impact of residual DNA template known to persist even after DNase treatment (NEB personnel communication). To verify that the product of RT-PCR was the result of the amplification of the reverse transcribed DNA, rather than the residual DNA template, identical PCR mixtures were prepared in the absence of reverse transcriptase (negative controls). RT-PCR resulted in DNA bands of approximately 700 bp for all IVT products, which was the expected size for the GFP gene (Fig. 5). Identically sized bands appeared in the control samples, but at a substantially reduced quantity, consistent with them resulting from amplification of residual input DNA. To investigate this further a DNase time course experiment was performed and revealed residual full-length DNA persisted after prolonged DNase treatment (Supplementary Fig. 4). Thus, we conclude that the DNA bands of approximately 700 bp in length are bona fide products of reverse transcription of RNA generated in the IVT reactions.
IVT time course
To assess the persistence/longevity of DNA nanoparticles in IVT reactions, a time course experiment was performed on the various DNA nanoparticle constructs. IVT products were extracted at 30, 60, 90, and 120 min of reaction time. An increase in RNA production was observed with all four promoter-bearing constructs, including the buried promoter, with no obvious variation in transcription kinetics. Thus, it appears that DNA nanoparticles remain transcription competent for at least 120 min in a controlled in vitro environment (Fig. 6).
Discussion
The self-assembly nanoengineering code embedded in nucleic acids has resulted in the production of DNA nanoparticles with myriad attributes1,7,21 and, in some instances, their implementation in various applications1–3,5–7,10–12,14–18. The applicability of DNA nanoparticles can be further amplified by the integration of expressible genes in their architecture. This latter point is reflected in a recent report in which a gene cassette folded into a DNA origami nanoparticle was utilized as the substrate for insertion at a genetic locus by a CRISPR/Cas9 editing system in cell culture. In that work, the inserted element was transcribed subsequently to linearization and insertion into the target chromosomal locus19. Furthermore, it was recently shown that DNA origami nanoparticles constructed using both sense and antisense gene-bearing scaffold strands can be expressed in cell culture20.
In the present study, we explore the possibility that expression can occur within the context of folded DNA nanoparticles that include a significant number of crossovers stereochemically analogous to Holiday junctions. The ability of a polymerase to navigate past a small number of Holliday junctions in linear duplex (i.e., not folded) DNA has been previously described36. In that study, it was revealed that Holliday junctions impede, but do not completely block polymerase progression. Here we show that even under conditions of extreme folding, high crossover density, and limited accessibility to the promoter, T7 RNA polymerase can initiate and complete the transcription of a full-length gene cassette. Kretzmann and colleagues have proposed that the unfolding of DNA nanoparticles is a prerequisite for gene expression in cell culture20. The study presented here suggests that, at least in vitro, DNA nanoparticles retain their structure prior to transcription and that the unfolding of the DNA nanoparticles occurs during the transcription event. This variation in the proposed mechanism is supported by the AGE results presented in Supplementary materials and the observed trend in differences in RNA production as a function of origami “compactness” (i.e., number, and local density of crossovers). Further delineation of the details involved in gene expression from sculpted DNA nanoparticles may permit regulation of the timing and level of gene expression via fine-tuning of their architectural features.
Finally, it is noteworthy that the chemical malleability of DNA nanoparticles allows them to be readily decorated with a variety of molecular and chemical species, offering mechanisms for enhanced biocompatibility and cellular targeting. For example, electrostatic coating of lipid nanoparticles can significantly enhance their in vivo stability5,11,37, various cell-penetrating peptides, as well as nuclear localization signals, can be employed through either conjugation or intercalation for targeted delivery to the nucleus for efficient subsequent gene expression14,38–41, and antigen-specific aptamers can be utilized for specific cell targeting10. Thus, self-assembling, gene-bearing DNA nanoparticles may constitute the centerpiece of a broadly applicable platform for targeted in vivo delivery of therapeutic proteins42–44, protein vaccines42–45, and gene editing systems46–50.
Conclusion
In summary, we have demonstrated that gene-bearing, self-assembling DNA nanoparticles formed by the method of DNA origami and containing a large number of crossover domains can be readily transcribed in vitro by T7 RNA polymerase. Crossover density (compactness) and architecturally controlled accessibility to the T7 promoter element can modulate transcription production. In conjunction with previous studies, these results further illustrate the potential of sculpted, gene-bearing, self-assembling DNA nanoparticles to offer significant value in biomedicine and related areas.
Supplementary Information
Abbreviations
- GFP
Green Fluorescent Protein
- IDT
Integrated DNA Technologies
- NEB
New England Biolabs
- dsDNA
Double-stranded DNA
- ssDNA
Single-stranded DNA
- dsT7EGFP
Double-stranded GFP gene
- ssT7EGFP
Single-stranded GFP gene
- IVT
in vitro Transcription
Author contributions
C.Y.O. conducted experiments, wrote the main manuscript text, and prepared all figures and tables. E.H. conceived of this project and co-developed the protocols and ideas that emerged during the course of this work. All authors reviewed the manuscript.
Funding
Presidential Interdisciplinary Research Seed Grant (PIRS), Iowa State University, Ames IA 50011.
Data availability
The datasets used and/or analyzed during the current study available from the corresponding author upon request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-023-39777-0.
References
- 1.Kearney CJ, Lucas CR, O’Brien FJ, Castro CE. DNA origami: Folded DNA-nanodevices that can direct and interpret cell behavior. Adv. Mater. 2016;28(27):5509–5524. doi: 10.1002/adma.201504733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ora A, Järvihaavisto E, Zhang H, Auvinen H, Santos HA, Kostiainen MA, Linko V. Cellular delivery of enzyme-loaded DNA origami. Chem. Commun. 2016;52(98):14161–14164. doi: 10.1039/c6cc08197e. [DOI] [PubMed] [Google Scholar]
- 3.Ramakrishnan S, Ijäs H, Linko V, Keller A. Structural stability of DNA origami nanostructures under application-specific conditions. Comput. Struct. Biotechnol. J. 2018;16:342–349. doi: 10.1016/j.csbj.2018.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mathur D, Medintz IL. Analyzing DNA nanotechnology: A call to arms for the analytical chemistry community. Anal. Chem. 2017;89(5):2646–2663. doi: 10.1021/acs.analchem.6b04033. [DOI] [PubMed] [Google Scholar]
- 5.Wang S-T, Gray MA, Xuan S, Lin Y, Byrnes J, Nguyen AI, Todorova N, Stevens MM, Bertozzi CR, Zuckermann RN, Gang O. DNA origami protection and molecular interfacing through engineered sequence-defined peptoids. PNAS. 2020;117(12):6339–6348. doi: 10.1073/pnas.1919749117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Daljit Singh JK, Luu MT, Abbas A, Wickham SFJ. Switchable DNA-origami nanostructures that respond to their environment and their applications. Biophys. Rev. 2018;10(5):1283–1293. doi: 10.1007/s12551-018-0462-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wang P, Meyer TA, Pan V, Dutta PK, Ke Y. The beauty and utility of DNA origami. Chem. 2017;2(3):359–382. [Google Scholar]
- 8.Coleridge EL, Dunn KE. Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours. Biomed. Phys. Eng. Express. 2020;6(6):0605030. doi: 10.1088/2057-1976/abbe73. [DOI] [PubMed] [Google Scholar]
- 9.Sprengel A, Lill P, Stegemann P, Bravo-Rodriguez K, Schöneweiβ E-C, Merdanovic M, Gudnason D, Aznauryan M, Gamrad L, Barcikowski S, Sanchez-Garcia E, Birkedal V, Gatsogiannis C, Ehrmann M, Saccà B. Tailored protein encapsulation into a DNA host using geometrically organized supramolecular interactions. Nat. Commun. 2017;8:14472. doi: 10.1038/ncomms14472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Li S, Jiang Q, Liu S, Zhang Y, Tian Y, Song C, Wang J, Zou Y, Anderson GJ, Han J-Y, Chang Y, Liu Y, Zhang C, Chen L, Zhou G, Nie G, Yan H, Ding B, Zhang Y. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat. Biotechnol. 2018;36:258–264. doi: 10.1038/nbt.4071. [DOI] [PubMed] [Google Scholar]
- 11.Dobrovolskaia MA, Bathe M. Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors. Wiley Interdiscip. Rev. 2021;13(1):e1657. doi: 10.1002/wnan.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ouyang X, Li J, Liu H, Zhao B, Yan J, Ma Y, Xiao S, Song S, Huang Q, Chao J, Fan C. Rolling circle amplification-based DNA origami nanostructures for intracellular delivery of immunostimulatory drugs. Small. 2013;9(18):3082–3087. doi: 10.1002/smll.201300458. [DOI] [PubMed] [Google Scholar]
- 13.Bastings MMC, Anastassacos FM, Ponnuswamy N, Leifer FG, Cuneo G, Lin C, Ingber DE, Ryu JH, Shih WM. Modulation of the cellular uptake of DNA origami through control over mass and shape. Nano Lett. 2018;18(6):3557–3564. doi: 10.1021/acs.nanolett.8b00660. [DOI] [PubMed] [Google Scholar]
- 14.Burns JR, Lamarre B, Pyne ALB, Noble JE, Ryadnov MG. DNA origami inside-out viruses. ACS Synth. Biol. 2018;7(3):767–773. doi: 10.1021/acssynbio.7b00278. [DOI] [PubMed] [Google Scholar]
- 15.Brglez J, Nikolov P, Angelin A, Niemeyer CM. Designed intercalators for modification of DNA origami surface properties. Chem. Eur. J. 2015;21(26):9440–9446. doi: 10.1002/chem.201500086. [DOI] [PubMed] [Google Scholar]
- 16.Chi Q, Yang Z, Xu K, Wang C, Liang H. DNA nanostructure as an efficient drug delivery platform for immunotherapy. Front Pharmacol. 2020;10:1585. doi: 10.3389/fphar.2019.01585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Madsen M, Gothelf KV. Chemistries for DNA Nanotechnology. Chem. Rev. 2019;119(10):6384–6458. doi: 10.1021/acs.chemrev.8b00570. [DOI] [PubMed] [Google Scholar]
- 18.Hannewald N, Winterwerber P, Zechel S, Ng DYW, Hager MD, Weil T, Schubert US. DNA origami meets polymers: A powerful tool for the design of defined nanostructures. Angew. Chem. Int. Ed. 2021;60(12):6218–6229. doi: 10.1002/anie.202005907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lin-Shiao E, Pfeifer WG, Shy BR, Doost MS, Chen E, Vykunta VS, Hamilton JR, Stahl EC, Lopez DM, Sandoval Espinoza CR, Deyanov AE, Lew RJ, Poirer MG, Marson A, Castro CE, Doudna JA. CRISPR-Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells. Nucleic Acids Res. 2022;50(3):1256–1268. doi: 10.1093/nar/gkac049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kretzmann JA, Liedl A, Monferrer A, Mykhailiuk V, Beerkens S, Dietz H. Gene-encoding DNA origami for mammalian cell expression. Nat. Commun. 2023;14:1017. doi: 10.1038/s41467-023-36601-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Rothemund PWK. Folding DNA to create nanoscale shapes and patterns. Nature. 2006;440:297–302. doi: 10.1038/nature04586. [DOI] [PubMed] [Google Scholar]
- 22.Chen X, Wang Q, Peng J, Long Q, Yu H, Li Z. Self-assembly of large DNA origami with custom-designed scaffolds. ACS Appl. Mater Interfaces. 2018;10(29):24344–24348. doi: 10.1021/acsami.8b09222. [DOI] [PubMed] [Google Scholar]
- 23.Bush J, Singh S, Vargas M, Oktay E, Hu C-H, Veneziano R. Synthesis of DNA origami scaffolds: Current and emerging strategies. Molecules. 2020;25(15):3386. doi: 10.3390/molecules25153386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Oh C-Y, Henderson ER. A comparison of methods for the production of kilobase-length single-stranded DNA. DNA. 2022;2(1):56–67. [Google Scholar]
- 25.Mathur D, Henderson ER. Programmable DNA Nanosystem for Molecular Interrogation. Sci. Rep. 2016;6:27413. doi: 10.1038/srep27413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Douglas SM, Marblestone AH, Teerapittayanon S, Vazquez A, Church GM, Shih WM. Rapid prototyping of 3D DNA-origami shapes with caDNAno. Nucleic Acids Res. 2009;37(15):5001–5006. doi: 10.1093/nar/gkp436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lin C, Perrault SD, Kwak M, Graf F, Shih WM. Purification of DNA-origami nanostructures by rate-zonal centrifugation. Nucleic Acids Res. 2013;41(2):e40. doi: 10.1093/nar/gks1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Shaw A, Benson E, Högberg B. Purification of functionalized DNA origami nanostructures. ACS Nano. 2015;9:4968–4975. doi: 10.1021/nn507035g. [DOI] [PubMed] [Google Scholar]
- 29.Yang M, Bakker D, Raghu D, Li ITS. A single strand: A simplified approach to DNA origami. Front. Chem. 2023;11:1126177. doi: 10.3389/fchem.2023.1126177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Arnaud-Barbe N, Cheynet-Sauvion V, Oriol G, Mandrand B, Mallet F. Transcription of RNA templates by T7 RNA polymerase. Nucleic Acids Res. 1998;26(15):3550–3554. doi: 10.1093/nar/26.15.3550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sarcar SN, Miller DL. A specific, promoter-independent activity of T7 RNA polymerase suggests a general model for DNA/RNA editing in single subunit RNA Polymerases. Sci. Rep. 2018;8(1):13885. doi: 10.1038/s41598-018-32231-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lyakhov DL, He B, Zhang X, Studier FW, Dunn JJ, Mcallister WT. Pausing and termination by bacteriophage T7 RNA polymerase. J. Mol. Biol. 1998;280(2):201–213. doi: 10.1006/jmbi.1998.1854. [DOI] [PubMed] [Google Scholar]
- 33.Song H, Kang C. Sequence-specific termination by T7 RNA polymerase requires formation of paused conformation prior to the point of RNA release. Genes Cells. 2001;6(4):291–301. doi: 10.1046/j.1365-2443.2001.00420.x. [DOI] [PubMed] [Google Scholar]
- 34.Újvári A, Martin CT. Identification of a minimal binding element within the T7 RNA polymerase promoter. J. Mol. Biol. 1997;273(4):775–781. doi: 10.1006/jmbi.1997.1350. [DOI] [PubMed] [Google Scholar]
- 35.Sousa R, Chung YJ, Rose JP, Wang B-C. Crystal structure of bacteriophage T7 RNA polymerase at 3.3 Å resolution. Nature. 1993;364:593–599. doi: 10.1038/364593a0. [DOI] [PubMed] [Google Scholar]
- 36.Pipathsouk A, Belotserkovskii BP, Hanawalt PC. When transcription goes on Holliday: Double Holliday junctions block RNA polymerase II transcription in vitro. Biochim. Biophys. Acta. 2017;1860(2):282–288. doi: 10.1016/j.bbagrm.2016.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Agarwal NP, Matthies M, Gür FN, Osada K, Schmidt TL. Block copolymer micellization as a protection strategy for DNA origami. Angew. Chem. Int. Ed. 2017;56(20):5460–5464. doi: 10.1002/anie.201608873. [DOI] [PubMed] [Google Scholar]
- 38.Bolhassani A, Jafarzade BS, Mardani G. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides. Peptides. 2017;87:50–63. doi: 10.1016/j.peptides.2016.11.011. [DOI] [PubMed] [Google Scholar]
- 39.Bogacheva M, Egorova A, Slita A, Maretina M, Baranov V, Kiselev A. Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery. Bioorg. Med. Chem. Lett. 2017;27:4781–4785. doi: 10.1016/j.bmcl.2017.10.001. [DOI] [PubMed] [Google Scholar]
- 40.Zanta MA, Belguise-Valladier P, Behr J-P. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. PNAS. 1999;96(1):91–96. doi: 10.1073/pnas.96.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Vinogradov SV, Zhang H, Mitin A, Warren G. Intercalating conjugates of PEG with nuclear localization signal (NLS) PEPTIDE. Polym. Prepr. 2008;49(2):434–435. [PMC free article] [PubMed] [Google Scholar]
- 42.Dimitrov DS. Therapeutic proteins. Methods Mol. Biol. 2012;899:1–26. doi: 10.1007/978-1-61779-921-1_1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.El Taher MF, Yaqeen A. Therapeutic proteins derived from recombinant DNA technology. Int. J. Curr. Microbiol. App. Sci. 2020;9(1):2024–2032. [Google Scholar]
- 44.Leader B, Baca QJ, Golan DE. Protein therapeutics; a summary and pharmacological classification. Nat. Rev. Drug Discov. 2008;7(1):21–39. doi: 10.1038/nrd2399. [DOI] [PubMed] [Google Scholar]
- 45.Pollet J, Chen W-H, Strych U. Recombinant protein vaccines, a proven approach against coronavirus pandemics. Adv. Drug Deliv. Rev. 2021;170:71–82. doi: 10.1016/j.addr.2021.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Wei T, Cheng Q, Min Y-L, Olson EN, Siegwart DJ. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 2020;11(1):3232. doi: 10.1038/s41467-020-17029-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kuhn J, et al. Delivery of Cas9/sgRNA ribonucleoprotein complexes via hydroxystearyl oligoamino amides. Bioconj. Chem. 2020;31(3):729–742. doi: 10.1021/acs.bioconjchem.9b00853. [DOI] [PubMed] [Google Scholar]
- 48.Li L, Hu S, Chen X. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities. Biomaterials. 2018;171:207–218. doi: 10.1016/j.biomaterials.2018.04.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Behr M, Zhou J, Xu B, Zhang H. In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges. Acta Pharm. Sin. B. 2021;11(8):2150–2171. doi: 10.1016/j.apsb.2021.05.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Chen G, Abdeen AA, Wang Y, Shahi PK, Robertson S, Xie R, Suzuki M, Pattnaik BR, Saha K, Gong S. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Nat. Nanotechnol. 2019;14:974–980. doi: 10.1038/s41565-019-0539-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets used and/or analyzed during the current study available from the corresponding author upon request.